Comparison

Aldometanib European Partner

Item no. HY-148189-25mg
Manufacturer MedChem Express
CASRN 2904601-67-6
Amount 25 mg
Quantity options 100 mg 10 mg 25 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.73
Formula C27H43Cl2IN2
Citations [1]Chen-Song Zhang, et al. The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK. Nat Metab. 2022 Oct 10.
Smiles CCCCCCCCCCCCCCCCN1C=C[N+](CC2=C(Cl)C=CC=C2Cl)=C1C.[I-]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias LXY-05-029
Available
Product Description
Aldometanib (LXY-05-029) is an orally active aldolase inhibitor. Aldometanib can activate lysosomal adenosine monophosphate-activated protein kinase (AMPK) and decreases blood glucose. Aldometanib can be used for the research of metabolic homeostasis[1].
StorageTemperature
4°C (Powder, sealed storage, away from moisture)
Shipping
Room Temperature
Manufacturers Applications
Metabolism-sugar/lipid metabolism
MolecularWeight
593.45
Clinical Information
No Development Reported
Manufacturers Research Area
Metabolic Disease
Solubility
DMSO : ≥ 100 mg/mL
Target
AMPK
Manufacturers Target
AMPK
Manufacturers Pathway
Epigenetics; PI3K/Akt/mTOR
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close